Brian Posner is listed as an executive officer on 8 SEC Form D filings by 1 issuer between Nov 2013 and Mar 2017: Alliqua BioMedical, Inc. (Yardley, PA — biotechnology — 2013–2017; $15M reported sold to 43 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside David Johnson (8 shared filings), Jeffrey Sklar (8 shared filings), Jerome Zeldis (8 shared filings), Joseph Leone (8 shared filings), David Stefansky (7 shared filings) and 9 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Brian. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 8 public filings for Brian Posner and found 6 differences: Bankruptcy case: David Stefansky and Jill L. Stefansky; No amendment in the last 12 months on an offering that may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.